Ina Radtke

18 papers receiving 1.4k citations

Hit Papers

BCR–ABL1 lymphoblastic leukaemia is characterized by the ...20082026201420202008200400600

Peers

Ina Radtke
Comparison fields: 5 of 81
  • Hematology 952
  • Public Health, Environmental and Occupational Health 642
  • Molecular Biology 596
  • Pediatrics, Perinatology and Child Health 235
  • Genetics 217
Replace Margit König with:
Margit König Austria
Jan Zuna Czechia
SC Raimondi United States
JW Janssen Germany
S Raimondi United States
Manoj Raghavan United Kingdom
FG Behm United States
Claire Schwab United Kingdom
Marie‐Josée Le Bris France
Phoenix A. Ho United States
Ina Radtke relative to Margit König Austria Margit König's profile →
Citations per field
00.5×3.0×
Margit König · 1×
Citations per year

Countries citing papers authored by Ina Radtke

Since Specialization
Citations

This map shows the geographic impact of Ina Radtke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ina Radtke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ina Radtke more than expected).

Fields of papers citing papers by Ina Radtke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ina Radtke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ina Radtke. The network helps show where Ina Radtke may publish in the future.

Co-authorship network of co-authors of Ina Radtke

This figure shows the co-authorship network connecting the top 25 collaborators of Ina Radtke. A scholar is included among the top collaborators of Ina Radtke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ina Radtke. Ina Radtke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 0
3 1
4 2
5 10
6 2
7 72
8 2
9 91
10 201
11 128
12 4
13
BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikarosbreakdown →
711
14 137
15 1
16 20
17 2
18 1
19 1
20 0

About Ina Radtke

Ina Radtke is a scholar working on Hematology, Cancer Research and Public Health, Environmental and Occupational Health, having authored 20 papers that have together received 1.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (8 papers) and Cancer Genomics and Diagnostics (7 papers). The work is most often cited by research in Hematology (952 citations), Public Health, Environmental and Occupational Health (642 citations) and Genetics (217 citations). Ina Radtke has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include James R. Downing, Charles G. Mullighan, Sheila Shurtleff, Letha A. Phillips, Jing Ma, Christopher B. Miller, Ching‐Hon Pui, Timothy P. Hughes, Deborah L. White and James Dalton. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Genes & Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026